PLUS1
162.60
0.36 (0.22%)
0.36 (0.22%)
Upgrade to Real-Time
Afterhours (Closed)
Low
133.65
High
173.65
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.36 | 0.22% | 162.60 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 162.44 | 160.84 | 163.11 | 162.69 | 162.24 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 92,785 | 8,353,662 | $ 162.49 | $ 1,357,394,892 | 7,814,641 | 133.65 - 173.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:13 | formt | 140 | $ 162.60 | USD |
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 428.05B | 2.63B | 2.63B | $ 82.06B | $ 17.72B | 5.63 | 25.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 3.75 | 2.31% | - | - |
Johnson and Johnson News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/20/2021 | 01:55 | TipRanks | Johnson & Johnson Earnings Preview: Here’s What You Need To.. |
| 4/19/2021 | 19:55 | Dow Jones News | Drugmakers Accused of Causing Opioid Addiction in Trial --.. |
| 4/19/2021 | 17:42 | Dow Jones News | Drugmakers Accused of Causing Opioid Addiction in Trial |
| 4/19/2021 | 17:07 | Seeking Alpha | Emergent Bio hurt by second steepest drop for the year as.. |
| 4/19/2021 | 16:30 | Seeking Alpha | JNJ will not pursue regulatory submission based on prostate.. |
| 4/19/2021 | 14:06 | Seeking Alpha | Johnson & Johnson Q1 2021 Earnings Preview |
| 4/19/2021 | 09:45 | Seeking Alpha | J&J vaccine was paused because of concerns over treating.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 161.10 | 163.11 | 156.53 | 160.44 | 9,540,391 | 1.50 | 0.93% |
| 1 Month | 158.99 | 167.03 | 156.53 | 162.21 | 7,595,720 | 3.61 | 2.27% |
| 3 Months | 165.11 | 173.65 | 151.47 | 162.17 | 8,219,139 | -2.51 | -1.52% |
| 6 Months | 148.66 | 173.65 | 133.65 | 156.19 | 7,780,406 | 13.94 | 9.38% |
| 1 Year | 150.20 | 173.65 | 133.65 | 152.10 | 7,271,884 | 12.40 | 8.26% |
| 3 Years | 127.63 | 173.65 | 109.16 | 140.37 | 7,414,246 | 34.97 | 27.4% |
| 5 Years | 111.65 | 173.65 | 109.16 | 135.42 | 6,733,360 | 50.95 | 45.63% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
